Letautiene Simona Rūta, Valuckas Konstantinas Povilas
Clinic of Conservative Tumor Treatment, Institute of Oncology, Vilnius University, Vilnius, Lithuania.
Medicina (Kaunas). 2006;42(4):314-20.
To evaluate prognostic importance of dosimetric parameters (V20, V30 and V40) in the incidence of lung radiation toxicity caused by external-beam radiation therapy in patients with lung cancer.
A total of 82 patients with lung cancer were analyzed prospectively. They were treated in the Oncology Institute of Vilnius University from 2002 to 2005. Three-dimensional conformal radiotherapy was administered to all patients; radiation dose was > or =50 Gy, delivered in daily fractions of 2 Gy. All patients received concurrent chemotherapy and part of them - surgery. All patients were evaluated before radiation therapy and after 3-, 6-, and 12-month follow-up. V20, V30, and V40 were calculated from dose-volume histograms using the Eclipse(TM) radiotherapy treatment planing system. Based on radiological findings and clinical symptoms radiation-induced lung injury (radiation pneumonitis and radiation fibrosis) was diagnosed.
Nearly half of patients (48%) developed grade < or =2 pulmonary toxicity according to the Subjective, Objective, Management and Analytic/Late Effects on Normal Tissues (SOMA/LENT) scale. The percentage volume of normal lung tissue receiving >20 Gy dose was 38%, >30 Gy--25%, and >40 Gy--18%. In patients free of radiation toxicity V20 was 30%, V30--22%, and V40--18%, and in patients with radiation-induced pulmonary toxicity V20 was 48%, V30--30%, and V40--18%.
Dosimetric parameters V20, V30, and V40 are significant predictive factors for radiation-induced pulmonary toxicity. At this time planned V20 and V30 are too high and they should be minimized in order to reduce radiation-induced pulmonary toxicity.
评估剂量学参数(V20、V30和V40)在肺癌患者外照射放疗所致肺部放射毒性发生率中的预后重要性。
前瞻性分析了82例肺癌患者。他们于2002年至2005年在维尔纽斯大学肿瘤研究所接受治疗。所有患者均接受三维适形放疗;放射剂量≥50 Gy,每日分次给予2 Gy。所有患者均接受同步化疗,部分患者接受手术。所有患者在放疗前以及随访3个月、6个月和12个月后进行评估。使用Eclipse(TM)放射治疗计划系统从剂量体积直方图中计算V20、V30和V40。根据影像学检查结果和临床症状诊断放射性肺损伤(放射性肺炎和放射性肺纤维化)。
根据主观、客观、管理和分析/正常组织晚期效应(SOMA/LENT)量表,近一半患者(48%)发生了≤2级肺部毒性。接受>20 Gy剂量的正常肺组织体积百分比为38%,>30 Gy为25%,>40 Gy为18%。无放射毒性的患者中,V20为30%,V30为22%,V40为18%;有放射性肺毒性的患者中,V20为48%,V30为30%,V40为18%。
剂量学参数V20、V30和V40是放射性肺毒性的重要预测因素。目前计划的V20和V30过高,应将其降至最低以降低放射性肺毒性。